Gainers & Losers
Tue Jul 08 2025 10:28:40- Kotak Mahindra Bank share price
- ₹2,224.503.61%
- Asian Paints share price
- ₹2,484.601.69%
- Ntpc share price
- ₹343.201.64%
- State Bank Of India share price
- ₹812.800.72%
- Hdfc Bank share price
- ₹2,001.500.72%
Active Stocks
Tue Jul 08 2025 10:29:07- Hdfc Bank share price
- ₹2,001.500.72%
- Reliance Industries share price
- ₹1,538.80-0.16%
- Tata Motors share price
- ₹693.250.64%
- Ntpc share price
- ₹343.201.64%
- Zee Entertainment Enterpri...
- ₹145.650.45%
Business News/Market/Market Stats/Alembic Pharmaceuticals share price/ Alembic Pharmaceuticals Profit Loss Annual
Alembic Pharmaceuticals Profit & Loss Annual
998.60 -3.00 (-0.30%)Updated : 08 Jul 2025
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 5,929.40 | 5,567.90 | 5,214.84 | 4,718.33 |
| Other Net | 8.32 | 2.39 | 1.61 | 0.93 |
| Diluted Weighted Average Shares | 19.66 | 19.66 | 19.66 | 19.66 |
| Gain( Loss)on Saleof Assets | 3.26 | 1.70 | -4.70 | 0.54 |
| Depreciation/ Amortization | 278.58 | 272.67 | 275.43 | 286.78 |
| Operating Income | 742.68 | 660.73 | 437.78 | 587.46 |
| Net Income | 583.42 | 615.83 | 341.98 | 520.93 |
| Income Availableto Com Excl Extra Ord | 583.42 | 615.82 | 341.99 | 520.94 |
| Other Operating Expenses Total | 26.07 | 21.40 | 17.57 | 12.67 |
| Net Income Before Taxes | 707.18 | 631.83 | 354.59 | 620.11 |
| Minority Interest | 1.41 | - | - | - |
| Net Income After Taxes | 582.01 | 615.83 | 341.98 | 515.65 |
| Income Availableto Com Incl Extra Ord | 583.42 | 615.82 | 341.99 | 520.94 |
| Costof Revenue Total | 2,316.60 | 2,174.07 | 2,174.70 | 1,844.03 |
| Gross Profit | 4,355.48 | 4,054.56 | 3,477.92 | 3,461.76 |
| Interest Inc( Exp) Net- Non- Op Total | -47.08 | -32.99 | -80.10 | 31.18 |
| Unusual Expense( Income) | -12.87 | 0.00 | 0.00 | - |
| Diluted Net Income | 583.42 | 615.82 | 341.99 | 520.94 |
| DPS- Common Stock Primary Issue | 11.00 | 11.00 | 8.00 | 10.00 |
| Provisionfor Income Taxes | 125.17 | 16.00 | 12.61 | 104.46 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 583.42 | 615.83 | 341.98 | 520.93 |
| Total Revenue | 6,672.08 | 6,228.63 | 5,652.62 | 5,305.79 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 6,672.08 | 6,228.63 | 5,652.62 | 5,305.79 |
| Selling/ General/ Admin Expenses Total | 2,869.81 | 2,715.31 | 2,178.21 | 1,945.86 |
| Diluted Normalized EPS | 29.01 | 31.25 | 17.63 | 26.48 |
| Research Development | 451.21 | 384.45 | 568.93 | 628.99 |
| Diluted EPS Excluding Extra Ord Items | 29.68 | 31.33 | 17.40 | 26.50 |
| Total Adjustmentsto Net Income | - | -0.10 | 0.10 | 0.10 |
| Equity In Affiliates | - | - | - | 5.28 |
*All figures in crores except per share values
Alembic Pharmaceuticals Quick Links
Alembic Pharmaceuticals Dividend Alembic Pharmaceuticals Bonus Alembic Pharmaceuticals News Alembic Pharmaceuticals AGM Alembic Pharmaceuticals Rights Alembic Pharmaceuticals Splits Alembic Pharmaceuticals Board Meetings Alembic Pharmaceuticals Key Metrics Alembic Pharmaceuticals Shareholdings Alembic Pharmaceuticals Balance Sheet Alembic Pharmaceuticals Cashflow Alembic Pharmaceuticals Q1 Results Alembic Pharmaceuticals Q2 Results Alembic Pharmaceuticals Q3 Results Alembic Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
2,224.50+77.50(3.61%)
2,484.60+41.20(1.69%)
343.20+5.55(1.64%)
3,440.60-226.25 (-6.17%)
1,165.40-10.05 (-0.85%)